Lora A. Tucker

701 total citations
15 papers, 577 citations indexed

About

Lora A. Tucker is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lora A. Tucker has authored 15 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Lora A. Tucker's work include HER2/EGFR in Cancer Research (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Peptidase Inhibition and Analysis (3 papers). Lora A. Tucker is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Peptidase Inhibition and Analysis (3 papers). Lora A. Tucker collaborates with scholars based in United States, United Kingdom and France. Lora A. Tucker's co-authors include Jieyi Wang, Mark G. Anderson, George S. Sheppard, Qian Zhang, Anatol Oleksijew, Kedar S. Vaidya, Edward B. Reilly, Erwin R. Boghaert, Randy L. Bell and Steven K. Davidsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Lora A. Tucker

15 papers receiving 562 citations

Peers

Lora A. Tucker

ONCOL

PRM

HEPAT

Fumi Kinose United States

Siham Djelloul France

Sebastian Trousil United Kingdom

Thomas H. Beckham United States

H Naundorf Germany

Jean‐Claude Marshall United States

Shinji Oie Japan

Michael P. Sheets United States

Corinne Venot France

Fumi Kinose United States

Lora A. Tucker

595 ×1.8

265 ×1.1

ONCOL

146 ×1.7

157 ×1.9

PRM

30 ×0.4

HEPAT

Citations per year, relative to Lora A. Tucker Lora A. Tucker (= 1×) peers Fumi Kinose

Countries citing papers authored by Lora A. Tucker

Since Specialization

Citations

This map shows the geographic impact of Lora A. Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora A. Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora A. Tucker more than expected).

Fields of papers citing papers by Lora A. Tucker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lora A. Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora A. Tucker. The network helps show where Lora A. Tucker may publish in the future.

Co-authorship network of co-authors of Lora A. Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of Lora A. Tucker. A scholar is included among the top collaborators of Lora A. Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lora A. Tucker. Lora A. Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Reilly, Regina M., Mark G. Anderson, Lora A. Tucker, et al.. (2023). Abstract 6311: ABBV-400: An ADC delivering a novel topoisomerase 1 inhibitor to c-Met-positive solid tumors. Cancer Research. 83(7_Supplement). 6311–6311. 7 indexed citations

Vaidya, Kedar S., Anatol Oleksijew, Lora A. Tucker, et al.. (2017). A “Prozone-Like” Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor Receptor. Pharmacology. 100(5-6). 229–242. 4 indexed citations

Wang, Jieyi, Mark G. Anderson, Anatol Oleksijew, et al.. (2016). ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET –Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence. Clinical Cancer Research. 23(4). 992–1000. 104 indexed citations

Wang, Jieyi, Liliane Goetsch, Lora A. Tucker, et al.. (2016). Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 16(1). 105–105. 50 indexed citations

Pappano, William N., et al.. (2014). Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells. BMC Cancer. 14(1). 430–430. 25 indexed citations

Fidanze, Steve, Scott Erickson, Gary T. Wang, et al.. (2010). Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 20(8). 2452–2455. 50 indexed citations

Wang, Gary T., Robert A. Mantei, Robert D. Hubbard, et al.. (2010). Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases. Bioorganic & Medicinal Chemistry Letters. 20(20). 6067–6071. 22 indexed citations

Warder, Scott E., Lora A. Tucker, Evelyn McKeegan, et al.. (2009). Reducing agent-mediated precipitation of high-abundance plasma proteins. Analytical Biochemistry. 387(2). 184–193. 48 indexed citations

Hubbard, Robert D., Nwe Y. BaMaung, Steve Fidanze, et al.. (2009). Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 19(6). 1718–1721. 17 indexed citations

10.

Anderson, Mark G., et al.. (2008). Inhibition of Aurora B kinase sensitizes a subset of human glioma cells to TRAIL concomitant with induction of TRAIL-R2. Cell Death and Differentiation. 16(3). 498–511. 29 indexed citations

11.

Wilsbacher, Julie L., Qian Zhang, Lora A. Tucker, et al.. (2008). Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation. Journal of Biological Chemistry. 283(35). 23721–23730. 22 indexed citations

12.

Tucker, Lora A., George S. Sheppard, Pei‐Jen Lou, et al.. (2008). Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation. Oncogene. 27(28). 3967–3976. 41 indexed citations

13.

Wang, Jieyi, Lora A. Tucker, Jason Stavropoulos, et al.. (2008). Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor. Proceedings of the National Academy of Sciences. 105(6). 1838–1843. 25 indexed citations

14.

Warder, Scott E., Lora A. Tucker, Shaun M. McLoughlin, et al.. (2008). Discovery, Identification, and Characterization of Candidate Pharmacodynamic Markers of Methionine Aminopeptidase-2 Inhibition. Journal of Proteome Research. 7(11). 4807–4820. 19 indexed citations

15.

Morgan-Lappe, Susan E., Lora A. Tucker, Xiaoli Huang, et al.. (2007). Identification of Ras-Related Nuclear Protein, Targeting Protein for Xenopus Kinesin-like Protein 2, and Stearoyl-CoA Desaturase 1 as Promising Cancer Targets from an RNAi-Based Screen. Cancer Research. 67(9). 4390–4398. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact